Skip to main content
Top
Published in: European Radiology 2/2024

20-12-2023 | Prostate Cancer | Commentary

Structured reporting in prostate cancer: the revolution of quality in nuclear medicine scan interpretation

Authors: Laura Evangelista, Luca Filippi

Published in: European Radiology | Issue 2/2024

Login to get access

Excerpt

The written radiology or nuclear medicine report serves as the cornerstone of diagnostic communication, encompassing image interpretation for educational, research, legal, and billing purposes. The adoption of structured reporting can enhance patient management, subsequently impacting their quality of life and prognosis. In the context of prostate cancer patients, various efforts have been undertaken to establish standardized imaging interpretation criteria. Different tools have been utilized, including the European Association of Nuclear Medicine (EANM) criteria, Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE), E-PSMA, Pro-PET, and PRIMARY Score. However, each of these tools has distinct interpretation criteria and also setting of disease, contributing to variable inter-reader variability. …
Literature
2.
go back to reference Dondi F, Lazzarato A, Gorica J et al (2023) PET criteria by cancer type from imaging interpretation to treatment response assessment: beyond FDG PET score. Life (Basel) 13:611 Dondi F, Lazzarato A, Gorica J et al (2023) PET criteria by cancer type from imaging interpretation to treatment response assessment: beyond FDG PET score. Life (Basel) 13:611
3.
go back to reference Leung KH, Rowe SP, Leal JP et al (2022) Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. EJNMMI Res 12(1):76CrossRefPubMedPubMedCentral Leung KH, Rowe SP, Leal JP et al (2022) Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. EJNMMI Res 12(1):76CrossRefPubMedPubMedCentral
4.
go back to reference Letang A, Crombé A, Rousseau C et al (2022) Bone uptake in prostate cancer patients: diagnostic performances of PSMA-RADS v1.0, clinical, biological, and 68 Ga-PSMA-11 PET features to predict metastasis after biochemical recurrence. Clin Nucl Med 47(8):e529–e539CrossRefPubMed Letang A, Crombé A, Rousseau C et al (2022) Bone uptake in prostate cancer patients: diagnostic performances of PSMA-RADS v1.0, clinical, biological, and 68 Ga-PSMA-11 PET features to predict metastasis after biochemical recurrence. Clin Nucl Med 47(8):e529–e539CrossRefPubMed
5.
go back to reference Kuten J, Dekalo S, Mintz I et al (2021) The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0. EJNMMI Res 11(1):3CrossRefPubMedPubMedCentral Kuten J, Dekalo S, Mintz I et al (2021) The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0. EJNMMI Res 11(1):3CrossRefPubMedPubMedCentral
6.
go back to reference Bhoil A, Seshadri N, Vinjamuri S (2022) Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS. Nucl Med Commun. 43(9):1034–1041CrossRefPubMed Bhoil A, Seshadri N, Vinjamuri S (2022) Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS. Nucl Med Commun. 43(9):1034–1041CrossRefPubMed
7.
go back to reference Chiu LW, Lawhn-Heath C, Behr SC et al (2020) Factors predicting metastatic disease in 68Ga-PSMA-11 PET-positive osseous lesions in prostate cancer. J Nucl Med. 61(12):1779–1785CrossRefPubMed Chiu LW, Lawhn-Heath C, Behr SC et al (2020) Factors predicting metastatic disease in 68Ga-PSMA-11 PET-positive osseous lesions in prostate cancer. J Nucl Med. 61(12):1779–1785CrossRefPubMed
8.
go back to reference Rowe SP, Li X, Trock BJ et al (2020) Prospective comparison of PET imaging with PSMA-targeted 18F-DCFPyL versus Na18F for bone lesion detection in patients with metastatic prostate cancer. J Nucl Med. 61(2):183–188CrossRefPubMedPubMedCentral Rowe SP, Li X, Trock BJ et al (2020) Prospective comparison of PET imaging with PSMA-targeted 18F-DCFPyL versus Na18F for bone lesion detection in patients with metastatic prostate cancer. J Nucl Med. 61(2):183–188CrossRefPubMedPubMedCentral
Metadata
Title
Structured reporting in prostate cancer: the revolution of quality in nuclear medicine scan interpretation
Authors
Laura Evangelista
Luca Filippi
Publication date
20-12-2023
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2024
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10507-4

Other articles of this Issue 2/2024

European Radiology 2/2024 Go to the issue